Long Genocea Biosciences when the price has fallen to last lows
"Genocea Biosciences Inc is a clinical stage biopharmaceutical company that discovers and develops novel vaccines to address infectious diseases for which no vaccine or vaccines with limited effectiveness exist today."
Potential risk:
"Company Insider Jessica Baker Flechtner (Sr. VP of Research) Sells 2,229 Shares of Genocea Biosciences, Inc. (GNCA). The Insider selling transaction was disclosed on Jun 2, 2015 to the Securities and Exchange Commission. "
thedailyrover.com/company-insider-jessica-baker-flechtner-sells-2229-shares-of-genocea-biosciences-inc-gnca/
Potential risk:
"Company Insider Jessica Baker Flechtner (Sr. VP of Research) Sells 2,229 Shares of Genocea Biosciences, Inc. (GNCA). The Insider selling transaction was disclosed on Jun 2, 2015 to the Securities and Exchange Commission. "
thedailyrover.com/company-insider-jessica-baker-flechtner-sells-2229-shares-of-genocea-biosciences-inc-gnca/
Exención de responsabilidad
La información y las publicaciones que ofrecemos, no implican ni constituyen un asesoramiento financiero, ni de inversión, trading o cualquier otro tipo de consejo o recomendación emitida o respaldada por TradingView. Puede obtener información adicional en las Condiciones de uso.